Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» COVID-19
COVID-19
FDA says IT modernization came at right time for COVID
RAPS.org
Thu, 03/31/22 - 11:30 pm
FDA
process modernization
pandemic
COVID-19
Senate nears $10 billion deal to buy Covid vaccines, therapeutics
Stat
Thu, 03/31/22 - 11:24 pm
Senate
COVID-19
Joe Biden
vaccines
pandemic
CureVac and GSK try again with COVID-19 vaccine
Pharmaforum
Thu, 03/31/22 - 10:21 am
GSK
CureVac
vaccines
COVID-19
MRNA
Adagio knows its COVID-19 antibody works against old variants. Can it win EUA in the era of omicron?
Fierce Biotech
Wed, 03/30/22 - 10:55 am
Adagio Therapeutics
FDA
COVID-19
antibodies
ADG20
Vaxxas strikes deal to tee up trial of COVID-19 vaccine patch
Fierce Pharma
Wed, 03/30/22 - 10:50 am
Vaxxas
vaccines
vaccine patches
COVID-19
U.S. approves second Covid-19 booster for people 50 and older
Stat
Tue, 03/29/22 - 11:47 pm
Pfizer
BioNTech
Moderna Therapeutics
FDA
vaccines
boosters
COVID-19
Plaintiffs sue Ellume over 'ill-gotten gains' from recalled COVID-19 tests
Medtech Dive
Tue, 03/29/22 - 10:35 am
Ellume
COVID-19
legal
diagnostics
Medtech
Icosavax's COVID-19 shot fails to deliver in early data, spurring debate about 'fatal flaw' in platform
Fierce Biotech
Mon, 03/28/22 - 10:28 am
Icosavax
vaccines
COVID-19
IVX-411
clinical trials
Officials limit an antibody therapy, saying it’s ineffective against BA.2 variant of Omicron
Stat
Sun, 03/27/22 - 04:00 pm
Vir Biotechnology
GSK
monoclonal antibodies
sotrovimab
COVID-19
Omicron BA.2
FDA
Big Pharma has skirted long Covid, but a pipeline of small biotechs are testing treatments for lingering symptoms
Endpoints
Sun, 03/27/22 - 03:58 pm
COVID-19
Long COVID
GSK
Vir Biotechnology
Humanigen
Pfizer
Roche
Atea Pharmaceuticals
Which Company Has the Biggest COVID Program? The Answer Isn't Moderna.
Motley Fool
Sun, 03/27/22 - 03:55 pm
COVID-19
Sorrento Therapeutics
Moderna Therapeutics
Pfizer
How Covid failed to derail the FDA
EP Vantage
Sun, 03/27/22 - 03:48 pm
COVID-19
FDA
regulatory
Moderna weighs private market debut for COVID shot as federal funding flounders
Fierce Pharma
Fri, 03/25/22 - 10:46 am
Moderna Therapeutics
vaccines
COVID-19
congress
A biotech developing a synthetic biology Covid-19 vaccine comes up short in first data readout — and investors are fleeing
Endpoints
Fri, 03/25/22 - 10:44 am
Icosavax
vaccines
COVID-19
clinical trials
Novavax Announces Participation in Two Booster Studies Using its COVID-19 Vaccine
BioSpace
Fri, 03/25/22 - 10:31 am
Novavax
vaccines
clinical trials
COVID-19
boosters
NVX-CoV2373
FDA urges COVID-19 test makers with EUAs to seek full authorizations
Medtech Dive
Fri, 03/25/22 - 10:25 am
diagnostics
FDA
COVID-19
Emergency Use Authorization
Moderna wants to give FDA ‘flexibility’ in deciding eligibility for 4th Covid shot, CEO says
CNBC
Thu, 03/24/22 - 08:30 pm
Moderna Therapeutics
vaccines
boosters
COVID-19
FDA
Evidence grows that vaccines lower the risk of getting long COVID
NPR
Thu, 03/24/22 - 10:48 am
COVID-19
vaccines
Long COVID
Moderna to ask FDA to authorize Covid-19 vaccine in children 6 months to 6 years
Stat
Wed, 03/23/22 - 10:42 am
Moderna Therapeutics
FDA
vaccines
COVID-19
pediatric
Moderna trains its mRNA tech on the common cold and a triple whammy against 3 respiratory diseases
Fierce Biotech
Tue, 03/22/22 - 10:49 am
Moderna Therapeutics
vaccines
MRNA
COVID-19
RSV
Flu
mRNA-1230
common cold
mRNA-1287
Pages
« first
‹ previous
…
26
27
28
29
30
31
32
33
34
…
next ›
last »